Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Long-Term Deferred Tax (2018 - 2025)

Historic Long-Term Deferred Tax for Pediatrix Medical (MD) over the last 8 years, with Q3 2025 value amounting to $79.8 million.

  • Pediatrix Medical's Long-Term Deferred Tax fell 3319.32% to $79.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.8 million, marking a year-over-year decrease of 3319.32%. This contributed to the annual value of $103.9 million for FY2024, which is 8487.17% down from last year.
  • Latest data reveals that Pediatrix Medical reported Long-Term Deferred Tax of $79.8 million as of Q3 2025, which was down 3319.32% from $88.7 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Long-Term Deferred Tax registered a high of $696.6 million during Q4 2022, and its lowest value of $56.3 million during Q2 2021.
  • Over the past 5 years, Pediatrix Medical's median Long-Term Deferred Tax value was $101.6 million (recorded in 2023), while the average stood at $187.1 million.
  • Per our database at Business Quant, Pediatrix Medical's Long-Term Deferred Tax skyrocketed by 6548.85% in 2022 and then tumbled by 8487.17% in 2024.
  • Over the past 5 years, Pediatrix Medical's Long-Term Deferred Tax (Quarter) stood at $673.6 million in 2021, then rose by 3.41% to $696.6 million in 2022, then fell by 1.45% to $686.5 million in 2023, then crashed by 84.87% to $103.9 million in 2024, then dropped by 23.2% to $79.8 million in 2025.
  • Its last three reported values are $79.8 million in Q3 2025, $88.7 million for Q2 2025, and $99.4 million during Q1 2025.